A quarter of people seeking care for symptoms of chronic respiratory diseases in Kenya may incur "catastrophic" health costs, new research published in The Lancet Global Health has found.
Jun 26, 2025
0
0
A new PET imaging technique can accurately detect and monitor Mycobacteroides abscessus lung infections—one of the most difficult-to-diagnose conditions in patients with lung diseases.
Jun 25, 2025
0
0
A new ICES study has found that 1.74 million patients in Ontario are attached to family physicians aged 65 or older, and that many of those patients are elderly and have complex medical needs.
Jun 17, 2025
0
0
A vaccine developed by University of Georgia researchers successfully protects against and treats vaginal yeast infections in mice, according to a newly published study in npj Vaccines.
Jun 17, 2025
0
45
Cells taken from the lungs of people with chronic obstructive pulmonary disease (COPD) have a larger accumulation of soot-like carbon deposits compared to cells taken from people who smoke but do not have COPD, according ...
Jun 10, 2025
0
0
Summer hasn't officially started, but already smoke from wildfires across the Prairie provinces has descended on us, sparking states of emergency and evoking memories of the 2023 wildfire season—the smokiest on record in ...
Jun 9, 2025
0
1
Walking is a fundamental activity for maintaining health. While numerous studies have assessed how much people with chronic obstructive pulmonary disease (COPD) walk, few have explored how they walk, especially in unsupervised, ...
Jun 5, 2025
0
0
His gaze softens as he draws closer to you. With one hand around your waist and the other cradling your jaw, he pulls you in. You look into his eyes, and notice his pupils have grown large and hungry.
Jun 3, 2025
0
0
Being exposed to lingering fine particulate matter (PM2.5) from wildfire smoke can have health effects for up to three months afterwards, well beyond the couple of days that previous studies have identified, and the exposure ...
May 28, 2025
0
0
The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD).
May 26, 2025
0
4
